PL3820528T3 - Solubilizator z kurkuminą i co najmniej jednym kannabinoidem jako dodatkową substancją czynną - Google Patents
Solubilizator z kurkuminą i co najmniej jednym kannabinoidem jako dodatkową substancją czynnąInfo
- Publication number
- PL3820528T3 PL3820528T3 PL19736404.5T PL19736404T PL3820528T3 PL 3820528 T3 PL3820528 T3 PL 3820528T3 PL 19736404 T PL19736404 T PL 19736404T PL 3820528 T3 PL3820528 T3 PL 3820528T3
- Authority
- PL
- Poland
- Prior art keywords
- solubilisate
- cannabinoid
- curcumin
- active agent
- further active
- Prior art date
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title 2
- 239000013543 active substance Substances 0.000 title 1
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 229940109262 curcumin Drugs 0.000 title 1
- 235000012754 curcumin Nutrition 0.000 title 1
- 239000004148 curcumin Substances 0.000 title 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2018/068731 WO2019011955A2 (de) | 2017-07-11 | 2018-07-11 | Solubilisat mit curcumin und optional zumindest einem weiteren wirkstoff |
PCT/EP2019/068537 WO2020011854A1 (de) | 2018-07-11 | 2019-07-10 | Solubilisat mit curcumin und zumindest einem cannabinoid als weiterem wirkstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3820528T3 true PL3820528T3 (pl) | 2024-01-29 |
Family
ID=67180795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL19736404.5T PL3820528T3 (pl) | 2018-07-11 | 2019-07-10 | Solubilizator z kurkuminą i co najmniej jednym kannabinoidem jako dodatkową substancją czynną |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP3820529B1 (pl) |
JP (2) | JP2021524488A (pl) |
KR (2) | KR102659259B1 (pl) |
CN (2) | CN112469444A (pl) |
BR (2) | BR112020026393A2 (pl) |
CA (2) | CA3102663A1 (pl) |
FI (1) | FI3820529T3 (pl) |
HR (1) | HRP20231263T1 (pl) |
PL (1) | PL3820528T3 (pl) |
PT (2) | PT3820528T (pl) |
WO (2) | WO2020011854A1 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4275694A1 (de) | 2022-05-13 | 2023-11-15 | Solmic Biotech GmbH | Verwendung von solubilisaten in erzeugnissen zur topischen anwendung |
WO2023139101A1 (de) | 2022-01-20 | 2023-07-27 | Solmic Biotech GmbH | Maske für medizinische oder kosmetische zwecke mit mizellierten extrakten |
WO2023250211A2 (en) * | 2022-06-24 | 2023-12-28 | Veroscience Llc | Treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease |
WO2024149451A1 (de) * | 2023-01-11 | 2024-07-18 | Aquanova Ag | Cannabinoidsolubilisat |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
US7279185B2 (en) | 2001-10-26 | 2007-10-09 | Metaproteonics, Llc | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
ATE321124T1 (de) * | 2002-12-18 | 2006-04-15 | Doehler Gmbh | Xanthohumol-haltiges getränk |
JP2005179213A (ja) | 2003-12-17 | 2005-07-07 | Kaneka Corp | 肝臓障害抑制作用組成物とその製造方法 |
JP2009514890A (ja) * | 2005-11-07 | 2009-04-09 | マーティ・ファーマシューティカルズ・インク | テトラヒドロカンナビノールの改良された送達 |
WO2008120220A1 (en) | 2007-04-03 | 2008-10-09 | Ganga Raju Gokaraju | Synergistic anti-inflammatory and antioxidant dietary supplement compositions |
CN103298443B (zh) * | 2011-01-06 | 2015-06-17 | 花王株式会社 | 水包油型乳化组合物 |
CN103861090B (zh) * | 2012-12-18 | 2017-06-13 | 美迪思生物科技(北京)有限公司 | 含蛋白或多肽的疏水溶液、其制备方法及用途 |
DE202012012130U1 (de) * | 2012-12-19 | 2014-03-21 | Aquanova Ag | Curcuminsolubilisat |
WO2015171445A1 (en) * | 2014-05-06 | 2015-11-12 | Mewa Singh | Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation |
WO2016022936A1 (en) * | 2014-08-07 | 2016-02-11 | Murty Pharmaceuticals, Inc. | An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts |
US20160081975A1 (en) * | 2014-09-18 | 2016-03-24 | Virun, Inc. | Soft gel compositions and pre-gel concentrates |
US20180280464A1 (en) * | 2015-10-15 | 2018-10-04 | Preleve Therapeutics, Llc | Compositions and Methods for Pain Relief |
JP6781974B2 (ja) | 2016-03-31 | 2020-11-11 | 国立大学法人 宮崎大学 | アドレノメデュリン凍結乾燥製剤の製造方法 |
IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
-
2019
- 2019-07-10 FI FIEP19736735.2T patent/FI3820529T3/en active
- 2019-07-10 PT PT197364045T patent/PT3820528T/pt unknown
- 2019-07-10 KR KR1020217003931A patent/KR102659259B1/ko active IP Right Grant
- 2019-07-10 EP EP19736735.2A patent/EP3820529B1/de active Active
- 2019-07-10 JP JP2021500617A patent/JP2021524488A/ja active Pending
- 2019-07-10 WO PCT/EP2019/068537 patent/WO2020011854A1/de active Application Filing
- 2019-07-10 CA CA3102663A patent/CA3102663A1/en active Pending
- 2019-07-10 CN CN201980046360.6A patent/CN112469444A/zh active Pending
- 2019-07-10 CA CA3103354A patent/CA3103354A1/en active Pending
- 2019-07-10 PT PT197367352T patent/PT3820529T/pt unknown
- 2019-07-10 PL PL19736404.5T patent/PL3820528T3/pl unknown
- 2019-07-10 WO PCT/EP2019/068538 patent/WO2020011855A1/de active Application Filing
- 2019-07-10 KR KR1020217003932A patent/KR20210032424A/ko active IP Right Grant
- 2019-07-10 HR HRP20231263TT patent/HRP20231263T1/hr unknown
- 2019-07-10 BR BR112020026393-1A patent/BR112020026393A2/pt unknown
- 2019-07-10 EP EP19736404.5A patent/EP3820528B1/de active Active
- 2019-07-10 CN CN201980046466.6A patent/CN112533638A/zh active Pending
- 2019-07-10 BR BR112020026362-1A patent/BR112020026362A2/pt unknown
- 2019-07-10 JP JP2021500589A patent/JP7254898B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
PT3820528T (pt) | 2023-10-26 |
WO2020011854A1 (de) | 2020-01-16 |
CN112469444A (zh) | 2021-03-09 |
CA3102663A1 (en) | 2020-01-16 |
PT3820529T (pt) | 2023-10-26 |
JP7254898B2 (ja) | 2023-04-10 |
EP3820528B1 (de) | 2023-08-30 |
JP2021524271A (ja) | 2021-09-13 |
KR20210032424A (ko) | 2021-03-24 |
WO2020011855A1 (de) | 2020-01-16 |
EP3820528A1 (de) | 2021-05-19 |
HRP20231263T1 (hr) | 2024-02-02 |
BR112020026362A2 (pt) | 2021-03-30 |
JP2021524488A (ja) | 2021-09-13 |
EP3820529B1 (de) | 2023-08-23 |
BR112020026393A2 (pt) | 2021-03-23 |
KR102659259B1 (ko) | 2024-04-23 |
CN112533638A (zh) | 2021-03-19 |
CA3103354A1 (en) | 2020-01-16 |
EP3820529A1 (de) | 2021-05-19 |
FI3820529T3 (en) | 2023-09-29 |
KR20210032423A (ko) | 2021-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE063768T2 (hu) | Kurkumint és további hatóanyagként legalább egy kannabinoidot tartalmazó szolubilizátum | |
PL3820528T3 (pl) | Solubilizator z kurkuminą i co najmniej jednym kannabinoidem jako dodatkową substancją czynną | |
IL284835A (en) | Pharmaceutical combination containing TNO155 and ribociclib | |
HK1243997B (zh) | Kv1.3抑制劑及其醫學應用 | |
IL278881A (en) | Cannabinoids and their use | |
IL287929A (en) | Cannabinoids and their uses | |
IL269305A (en) | Cannabinoid formulations and dosage | |
GB201805095D0 (en) | Compostion, method and use | |
EP3583934A4 (en) | BIOCIDAL AGENT | |
EP3515758A4 (en) | LEVER TENSIONERS AND OVERLOAD INDICATORS | |
EP3808738A4 (en) | PYRAZOLE DERIVATIVE AND PEST CONTROL AGENT | |
EP3892093A4 (en) | PESTICIDE SPRAY | |
GB201707469D0 (en) | Antimicrobial and antifungal agent | |
SG11202110640UA (en) | Antimicrobial agent | |
HK1243998A1 (zh) | Kv1.3抑制劑及其醫學應用 | |
EP3601246C0 (en) | 16-METHYL-OXACYCLOHEXADECAN-2-ONE AND 16-METHYL-AZACYCLOHEXADECAN-2-ONE DERIVATIVES AS ANTIMICROBIAL AGENTS | |
IL256312A (en) | Antibacterial preparations containing minocycline and oxidized cellulose | |
AU2017902650A0 (en) | Preserving Buildings and other Assets from Bushfires |